薬局におけるインシデント事例の集計･分析結果
|
|
|
- まさとし かやぬま
- 2 years ago
- Views:
Transcription
1
2
3
4 , H H
5 (
6
7
8 (42.5) 34.3 (8.3)
9 ,
10 7
11
12 1.6 9
13 10 this page is blank
14
15
16 mg T
17 Cap
18 Cap Cap Cap Cap Cap
19 mg IU T
20 g g g 1.0g g
21 45 0.5g 46 g 7.5g mg mg 200mg % ml 2.5ml ml 51 ml 2.5ml ml 50ml -18-
22 /2 1/ /2 1/2 1/
23 100mg 97% g % 0.3g 3.0g g 1.0g g g g
24 g mg mg 40 1g 400mg mg 0.1% 2.5g 14 35g 3.5g 10% 1200mg g 1200mg 12g mg DS 12.0g 1.2g g g 0.8g % 0.4g 0.2g mg 12 60mg 4 12 mg -21-
25 13 0.1% g 0.045g mg g 0.005g 0.045g % 400mg 50% 1g 500mg 200mg 0.8g 2.0g -22-
26 DS 20% 400mg g 18 50% 50mg/g mg/g mg/g 100mg/g 200mg/g 400mg/g 100mg/g ml 95ml 23 g 0.5g 0.5g 0.75g 1.0g g -23-
27 g g g 6.50g g 1.3g 1.3g 1.0g 26 g 1.5g 0.5g 0.67g 0.33g 0.5g0.67g1.0g 27 g g g 1g 1g 1g -24-
28 29 100mg 6ml 94 ml ml 10% 100mg 1ml 100mg 100mg/1ml g 1.5g 1.5g 2.0g 1.5g 1.5g 31 10g 5g 10g 10g % 1.5g 0.1% 3.0g mg 100mg % g g 0.3g g 2.4g -25-
29 37 20g g 5g g g g g 5g g 1.5g 1.5g 1.5g 1.5g 1.5g 43 DS -26-
30 DS0.7g g 1.95g % 0.002% 1.5% g 0.2g 0.2g 0.2g 0.2g g -27-
31 49 1% 0.1g 0.1g g 3.0g 2.1g 3.0g % g 1.5g 1.5g 0.5g g N g 100 g g g mg day 400mg day mg/g 110mg 100mg/g 100mg 100mg
32 56 57 DS 0.2%
33 100mg 97% 10% 97% g
34 % 0.5% 0.1% mg
35 mg 20mg 20mg 20mg mg mg mg 20mg 20mg mg 0.05mg mg 20mg 30mg 20mg g 0.5 g 0.5 g 0.5 g -32-
36 15 5 1/ mg
37 mg g 50 g 50 g CR 20 CR CR 20 CR mg 90mg S S 1.5g 90mg
38 27 20mg 20mg 40mg 20mg 20mg mg mg 100mg 50mg 29 mg 5mg 10mg 30 1mg 5mg mg 2.17mg -35-
39 5mg 2.5mg % 1.0% % 2% 2% 0.5% g 1.0g
40 DS 10% DSW 20% D 10 D 20 2% 10% g 1g g 1.5g % 1%
41 g 50 g D mg/1g DS 1mg/1g
42 L g 0.67g 1.0g % 1% g 0.75g 1.0g % 0.5% % 10% % 1% % 0.1%
43 mg mg 1.0mg 2.0mg D % 3% 5% 10% 0.5% 1% 0.25% 0.5% G 0.5% 1%
44 2.17mg 4.33mg % 0.1% % 0.5% 0.1% 0.01% N N g 30g 2g 5g 5g 30g 5g 30g
45 Tarivid otic solution Tarivid ophthalmic solution / 10% 50g g
46 mg 5mg 100mg mg 10mg -43-
47 / mg
48 Cap 10mg 20mg 10mg 20mg mg 330mg
49 farom flomox mg mg 200mg 40mg 40mg mg 100mg 200mg 200 g mg 4mg -46-
50 0.4mg 0.4mg 2mg 2mg mg 200mg mg 0.25mg
51 -48-
52 mg mg mg 330mg mg 100mg
53 mg 50mg mg g
54 Sup % 27 50mg 20mg 20mg 50mg
55 mg mg 1/2 5mg 1/ mg
56 K 0.1 C % % -53-
57 mg 0.025% g 1.0g DS 0.5% 12.5% DS -54-
58 DS DS DS DS DS DS DS DS DS DS DS DS DS DS DS DS DS DS DS
59 44 0.5g 0.5g IU
60 48 Cap mg 1mg mg 100mg
61
62 100mg 250mg
63 0.5g NSAID
64 Al Mg 21 50mg
65 mg
66 mg 18mg 24mg 12mg g
67 6.0g 10 10% 100 1% mg 1% 10mg 1% 0.2g 2g 15mg 1.5mg -64-
68 10 1.0g 0.1g 50% 2.0g 50% 0.2g 0.9mg 2.9mg g g Cap Cap 30 Cap
69 g 0.065g kg DS1.2g DS 0.5mg kg 0.75mg kg % g mg 2/ mg Cap Cap
70 23 12ml g 10 12ml 12ml % mg 0.5% g 15.5kg 25 5ml g g g g -67-
71 g g R 300 R
72 35 6mg K
73 g g 0.4 g 1.2 g g 0.12 g 0.12 g
74 mg % 0.5% 50 g g
75 T T
76 ml ml ml ml ml ml g 1g g TD 4.5g 4.5g 13.5g -73-
77 65 750mg day day 66 12ml 12ml ml VG 5g g g -74-
78 g 1.5g -75-
79
80
81 mg 25mg /
82 mg
83 mg mg
84 ml 20ml 10ml
85
86
87 79 81mg -84-
88 10 Rp Rp Rp Rp
89
90
91 or -88-
92
93
94 -91-
95
96 -93-
97
98 %
99 11 12,,,, enter D Cap Cap -96-
100 mg 2 31 Cap Cap
101 g 0.1g 0.015g 0.15g 34 1mg 0.5mg 1% 100 Cap 35 Cap
102
103 /4 3/
104
105
106 DS0.7g g 7.5g 12g 10 2ml 2ml Cap mg mg 1/ mg 2/
107 16 5mg
108 mg0.5 20mg0.5 20mg0.5 10mg
109
110 ,
111
112 -111 -
113 -112 -
114 -113 -
115 -114 -
116 loss prevention
117 p
118
119 1.2g 1.2g 0.12g g 6.0g g 0.06g 14 10ml
120 mg 100mg
121 1000g g
122
123
124
125
126
I
I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4
Taro9-医薬品目次２０１２－１.PDF
5 0.1% 11 250mg 10 20mg 10 5ml 19 0.05% 13 1.25mg 10 1%5ml 19 10mg 10 0.2%100ml 18 25%50ml 9 2mg 17 5%250ml 9 20%25g 20 500 g 11 4 10g 20 Cap150mg 1 200mg 0 Cap90mg 5 20mg 10 10% 5 18 10mg 10 3%30g 20
23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
レイアウト 1
1 3 6 7 8 3 6 7 8 g mg 6 1 16 16 18 16 13 138 13 16 1 11 8 78 8 17 9 9 g mg 18 13 1 1 1 99 6 3 36 3 3 8 1 18 18 18 16 16 1 1 g mg 1 1 13 13 1 11 11 g mg 8 6 g 1 g mg 93 38 9 93 8 8 176 1 1 1 1 11 18
- 1 - A B C D E or or D or or d - 2 - A p18 P19 P21-3 - - 4 - B 2001 P21 P18 P19-5 - - 6 - C P21-7 - - 8 - D P21-9 - P16-10 - E - 11 - RT-PCR - 12 - P16-13 - P21-14 - P16-15 - - 16 - - 17 - Yes No Yes
A B A E
10533-68-3955 10533-68-3955 10533-68-3804 RP A-6 10533-68-3804 10533-69-9615 10533-57-2161 B-2 10533-68-2274 10533-68-2221 10533-67-6282 A-6 10533-57-2161 E-3 10533-68-5161 10533-68-3553 D-2 D-2 10533-69-5258
d-00
283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685
Netcommunity SYSTEM X7000 IPコードレス電話機 取扱説明書
4 5 6 7 8 9 . 4 DS 0 4 5 4 4 4 5 5 6 7 8 9 0 4 5 6 7 8 9 4 5 6 4 0 4 4 4 4 5 6 7 8 9 40 4 4 4 4 44 45 4 6 7 5 46 47 4 5 6 48 49 50 5 4 5 4 5 6 5 5 6 4 54 4 5 6 7 55 5 6 4 56 4 5 6 57 4 5 6 7 58 4
.A. D.S
1999-1- .A. D.S 1996 2001 1999-2- -3- 1 p.16 17 18 19 2-4- 1-5- 1~2 1~2 2 5 1 34 2 10 3 2.6 2.85 3.05 2.9 2.9 3.16 4 7 9 9 17 9 25 10 3 10 8 10 17 10 18 10 22 11 29-6- 1 p.1-7- p.5-8- p.9 10 12 13-9- 2
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
² ² ² ²
² ² ² ² n=44 n =44 n=44 n=44 20.5% 22.7% 13.6% 27.3% 54.5% 25.0% 59.1% 18.2% 70.5% 15.9% 47.7% 25.0% 60% 40% 20% 0% n=44 52.3% 27.3% 11.4% 6.8% 27.55.5 306 336.6 408 n=44 9.1% 6.8% n=44 6.8% 2.3% 31.8%
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
RP. 1 15 5 0.5g/ 1 1 1 2 1 2 28 5mg/ 1 1 1 3 20 105 S-1 4 2 2 3 3 day15 15 S-115 S-1 S-1 0.12 0.22 0.12 106 2 107 3 65S-13day15 S-1 S-1 108 109 1 1 S-1 33-1 S-1 110 S-1 3day15 1 4 2 116 -1 5 1-2 2-3 day3
３．ごみの減量方法.PDF
- 7 - - 8 - - 9 - - 10 - - 11 - - 12 - ( 100 ( 100 - 13-123,550,846 111,195,762 92,663,135 ( 12 25 37 49.2 16 33 49 65.6 15 30 44 59.0 2.5kg) ( 5kg) ( 7.5kg) ( k ( 123,550,846 111,195,762 92,663,135 (
16 41 17 22 12 10
1914 11 1897 99 16 41 17 22 12 10 11 10 18 11 2618 12 22 28 15 1912 13 191516 2,930 1914 5,100 43 1.25 11 14 25 34364511 7.54 191420 434849 72 191536 1739 17 1918 1915 60 1913 70 10 10 10 99.5 1898 19034.17.6
製品案内 価格表 2014/4/1
4 (17) 3 43 5/20370/ 231(504,150) 11 12 10 14-16 10 3 100 17 100kg 5-6 3 13 3 18 18 # # # # #$$ %&$ ' ()* +,-% ' #). +,-%'% / ' # # #$ %&&&'( %)* +'(#$ #$ %&&&'( ++,-). +'(#$ #$ /'( + /0)- +'(#$ %&&&'(
ビットリアカップ2007けいはんなサイクルレースリザルト
Page 4/30 Page 5/30 Page 6/30 Page 7/30 Page 8/30 Page 9/30 Page 10/30 Page 11/30 Page 12/30 Page 13/30 Page 14/30 Page 15/30 Page 16/30 Page 17/30 Page 18/30 Page 19/30 Page 20/30 Page 21/30 Page 22/30
Page 1
Page 1 Page 2 Page 3 Page 4 620 628 579-41 -6.7-49 -7.9 71 41 47-24 -33.3 6 15.9 11.5 6.5 8.1 36 15 22-14 -38.9 7 43.4 Page 5 277 302 23 24 12/3Q 12/4Q 13/1Q 13/2Q 13/3Q 13/4Q 14/1Q 14/2Q 14/3Q 14/4Q 15/1Q
untitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
: : 2001227 : 2
: : 2001227 : 2 mg/100gmg/100g mg/100g 3 10/102006 12/05 2/19, 2007 Zn 63 98 4 10% 5 Ramesh et al. 2004 6 Connoly et al. 2002 A IRT 7 8 2.11mg/100g143%56% 9 10 Alaria praelonga 11 2 12 13 14 15 16 1 1
2
() () 980-8578 Tel: 022-795-6092 Fax: 022-795-6096 email: 1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 17 46 47 4.1.1
152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1
152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1 JAS 1-2 1-2 112 13 1-11-13 100870mg 100830mg11000 1100020.002 2 50 100 2 100 500 2 100 109252165 4514782 7 2.0kg 2-19220.05kg0.2kg
untitled
186 17 100160250 1 10.1 55 2 18.5 6.9 100 38 17 3.2 17 8.4 45 3.9 53 1.6 22 7.3 100 2.3 31 3.4 47 OR OR 3 1.20.76 63.4 2.16 4 38,937101,118 17 17 17 5 1,765 1,424 854 794 108 839 628 173 389 339 57 6 18613
untitled
1. 3 14 2. 1 12 9 7.1 3. 5 10 17 8 5500 4. 6 11 5. 1 12 101977 1 21 45.31982.9.4 79.71996 / 1997 89.21983 41.01902 6. 7 5 10 2004 30 16.8 37.5 3.3 2004 10.0 7.5 37.0 2004 8. 2 7 9. 6 11 46 37 25 55 10.
0.02ml IgE RAST MAST CAP 2
( ) 1 0.02ml IgE RAST MAST CAP 2 3 1963 30 4 1986 20 39 IgE 30% 1988 54.7% IgE 47.6% 1990 892 IgE 27% 12% 1995 2379 1995 8 15 1996 1 12 2335 98.5% 2335 24 61 47 44.0 1 1) 2335 613 26.3% 2 5 613 43.4 44.2
橡アロマセラピー症状別処方例.PDF
1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20
無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
.N...[..7...doc
1 2 3 STEP1 4 STEP2 STEP3 5 6 7 8 9 1 Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution of Solution
Page () &
() () Page () & Page 110kg 67kg 138kg Page Page Page Page, Page () (S3)(S1 (S2) (S1) (S2)(S1) (S3) (S1) (A2)(A1) (A3)(S1) (S3)(S1) (A2)(A1) (A3)(A1) (A3) (A1) (S2) (S1) Page () 10 () () () () () () ()
cable_nyuko_070605.indd
Solution Now Solution Now 01 Solution Now 02 Solution Now 03 Solution Now 04 Solution Now Solution Now 01 Solution Now 02 Solution Now 03 Solution Now 04 Solution Now Solution
油汚染鳥救護のガイドライン
9 1 1300 12 12 11 NGO 18 419 1804 NGO 19 3 1 1 ( ) 5 ( ) 11 ( ) 13 () 13 () 14 () 14 () 16 () 18 () 23 [ ] ( ) 25 25 26 26 33 34 35 [ ] 36 ( ) 37 () 39 () 39 () 40 () 42 () 42 2 () () () () 45 48 50 50
22.5.1
22.5.1 78 This is 10 10 21 H21H25H25 1 2 3 4 5 1 2 1 2 3 1 945 65 295 375 65 1,865 1,005 282 1 25 2 4 6 6 9 53 2 5,000 5,000 114 4/10 1/10 1/10 3,77082
橡サプリメント.PDF
Vol.13,No.1,2004 1 Feb.200Vol.13 No.1 Vol.13,No1,2004 2 70) ph H2 P450 P450 70) Vol.13,No.1,2004 ALDH N- H2 P-450 H2 ADH ADH ADH CYP ADH 200mg/dl ADH P-450CYP CYP CYP 17)18) N- 1 48g ADH 3 Vol.13,No1,2004
-1-19 753-0214 TEL 083-927-7031083-927-7029 FAX 083-927-0214 e-mail a17201@pref.yamaguchi.lg.jp - 2 - -3-. 20kg 60% 2kg 2 3 -4-30 3 15 3-0.05 0.4 NaOH 0.5 20 -5-. 1 1,757g 69% 30 -6- -7- -8- C C H17 18
14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
a
1 a b c a b a 2 kg ms/cm 20 40 60 80 20 40 60 80 20 40 60 80 15 18 22 25 11 14 24 25 9 24 31 31 3? 32 32 26 33 33 33 33 33 30 29 30 14?? 21 28 9 16 22 26 11 16 22 24 11 14 17 15 10 11 22 25 7 12 26 30
2 / 7
1 / 7 1.30 1.301.00m 2.00 2.001.00m 1.70 1.701.00m 2.4 2.41.0m 2.0 2.01.0m 1.08 1.20.9m 1.08 1.20.9m 2.5 2.51.0m 2.5 2.51.0m 0.9 1.00.9m 1.44 1.60.9m 2 / 7 ml ml 3 / 7 4 / 7 ) 5 / 7 6 / 7 0798-56-1710
12„”‡Pfiú“ƒ-PDFŠp
5 Q Q Q Q ggg g f bbb -b b g b g g g a b f g r t y - 7 g bb f 6 E D f f f 2 2 2 2 2 f g f 2 f 2 f 2 g a g a b f a f g a a a - a f b a f b b b b bb bb E E E R Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q
6 12 10661 93100 227213202 222208197 85kg cm 20 64.521 106856142 2 1 4 3 9767 100 35 cm 7747 208198 90kg 23 5828 10661 93100 cm 227213202 10639 61 64.521 85kg 78kg 70kg 61 100 197204.5 cm 15 61
<82D282A982C1746F95F18D908F57967B95B E696E6464>
1 2 (90cm 70cm 2015) 3 (68cm 28cm 30cm 12kg 2015) (77.5 109.5cm 2015) 4 (22cm 50cm 50cm 4.6kg 2015) (45cm 62.5cm 2015) (47.4cm 62.5cm 2014) 5 (28.5cm 23.5cm) (45cm 62cm 2015) (97cm 107cm 2015) 6 7 8 9
- 1 - 15 2030 4 21 21-2 - 2 1 21 21 4 22 31 10 5 26 ( JA ) - 3 - 4 21 7 9 9 34 1,386 1,003 94 58 1,155 60 25 33 1 3 2-4 - 12 17 60 7 7 12 H1217 4 7 30 34 19-5 - - 6 - (BMI*18.5) 20 15.2%30 8.% 20 86.4%30
10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2
サンプル一覧表.PDF
: 1 30 1 : 1 30 : 8662 60 : 4810 30 1 : 19383 90 : 8872 : 6279 : 7098 180 120 90 : 6405 120 : 7234 :3276 60 280 : 8053 180 : 5512 180 : 4368 100 :4462 120 : 4725 120 : 8851 180 : 3024 180 : 3286 150 :
2 (1) (2) SCI 2 SCI 2 24 2 12 2
2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1
180 140 22
21 180 140 22 23 25 50 1 3 350 140 500cm 600 140 24 25 26 27 28 29 30 31 1/12 8.3 1/15 6.7 10 1/8 12.5 1/20 140 90 75 150 60 150 10 30 15 35 2,000 30 32 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 % 100 50 33.3
1 2 3 4
LC-32GH1 LC-32GH2 1 2 3 4 5 4 6 7 8 9 10 11 1 2 3 4444444444 4444444 444444444 OIL BAR BAR CLINIC CLINIC 1 2 1 2 1 2 3 4 1 2 1 2 See page 44 if you wish to display menu screens
-51-
-50- -51- 11 3 28 8 1 24 7 2 36 10 1-52- -53- 1 2-54- 6 1 2 3 4 5 6 6 1 19 5 200 300ml 20 6 400ml -55- -56- 10-57- 4 2 20-58- 2,500-59- -60- -61- 2-62- 6 3-63- 9 68 1 6-64- 3-65- 4-66- 5 6-67- -68- 1 1
2006年3月8日
18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl
2014 6 115 123 総 説 I -VG, 2014 7 24 2014 8 15 -VG, -VG 115
2014 6 107 114 総 説 2014 7 25 2014 8 1 2014 1 20 OTC 107 2014 6 115 123 総 説 I -VG, 2014 7 24 2014 8 15 -VG, -VG 115 2014 6 124 132 原 著 1, 2, 3 4, 5 6 7 8 9 10 3 11 12 1 2 3 4 5 6 7 8 9 10 11 12 2014 3 24
橡DI月報１７8.PDF
2002.5.10. DI 22-2668 HCV HCV 1 1 375mg/ 13 60mg 20mg 1 20mg 1 750mg 1 400mg 3 1 2 7 IAB IAB IAB IAB IAB HIV ( ) HIV CYP3A4 HIV ( ) CYP3A4 WBC CK CK 1) 2) Torsades de Pointes K ) ALT AST -GTP CYP2C9 CYP2C19
経済論集 ４６‐１（よこ）（Ｐ）／２．三崎
1 1 14 2 1866 8 20 20 2 4 1871 20 3 4 2 1969 9 12 28 33 3 1970 35 5 1965 p.119. 1995 p.67 1960 p.86. 1965 p.120. 1927 p.5. 1942 p.127, p.129. 10 1877 7 12 16 6 10 7 10 1877 8 7 6 8 16 25 29 10 1877 9 1
untitled
280 200 5 7,800 6 8,600 28 1 1 18 7 8 2 ( 31 ) 7 42 2 / / / / / / / / / / 1 3 (1) 4 5 3 1 1 1 A B C D 6 (1) -----) (2) -- ()) (3) ----(). ()() () ( )( )( )( ) ( ) ( )( )( )( ) () (). () ()() 7 () ( ) 1
62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -
![62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -](/thumbs/41/22310901.jpg "62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -")
1 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] g/dl A 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - [ ] Point ~ 62 [ ] [ ] [ ] [ ] [ ] [ ] / /
untitled
magio 1 magio g g g g gg g gg g 2 g g g g g g 3 4 g g g g g g g g g g g 5 g g g g g g g g g 6 g g g g g g g g 7 g g g g g 8 g imagio MP 6000 T.38 imagio MP 6000 g g g imagio MP 6000 9 g g g g g 10 g gg
パ エ リ ア 材 料 (8 人 分 ) 食 材 塩 こしょう 各 少 々 1.5 1.5 1.5 1.5 30 30 30 30 6 3 1 1. 1/2 ( ) ( ) 2 200g 30ml 2 3 3 1 1/3 1 2. 5mm 3. 5 6mm 4. No No 2 1 1 2 8 kg 6:00 8:00 9:00 10:00 12:00 13:00 14:00 15:00 18:00
消費データ付きアンケート作成マニュアル
... 3... 4... 4... 5... 6... 6... 7... 8... 9... 14... 16... 17... 20... 24... 24... 25... 25... 25... 26... 27... 28... 29... 33... 34... 35... 35... 36... 37... 38... 39... 40... 41... 42... 43... 44...
消費データ付きアンケート作成マニュアル
... 3... 4... 4... 5... 6... 6... 7... 8... 9... 11... 15... 16... 18... 19... 22... 26... 26... 27... 27... 27... 28... 29... 30... 31... 35... 36... 37... 37... 38... 39... 40...41... 42... 43... 44...
MC-440 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
Microsoft, Windows Microsoft Corporation
Copyright 2000-2002 T&D Corporation. All rights reserved. 2002.07 16004194030 Microsoft, Windows Microsoft Corporation This Modem Logger is designed for use in Japan only and can not be used in any other
ml ml ml mg ml ml mm mm mm mm mm mm mm mm mm mm mm ml mmhg mmhg ml Acetylcholine ml mg mm mm mm mm mm mm ope ++ Uribe Davis S H S S : : : : : : : : : G
報告書
1 2 3 4 5 6 7 or 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 2.65 2.45 2.31 2.30 2.29 1.95 1.79 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 60 55 60 75 25 23 6064 65 60 1015